Mozart Therapeutics, the leading developer of CD8 Treg network modulators for the treatment of autoimmune disease, today ...

Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, April 23, 2026-Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage ...

The Phase II trial enrolled 129 participants, of whom 94% had relapsing remitting multiple sclerosis, and 6% had secondary ...

Superconductors, materials that can conduct electricity with a resistance of zero, have proved to be highly promising for the ...

Scientists have unveiled a breakthrough imaging method that can capture the hidden details of events unfolding in trillionths ...

A tiny silica bead, just 100 nanometers across, sits suspended in a vacuum and vibrates under the grip of laser light. Those ...

A novel imaging method captures ultrafast events with unprecedented detail by combining laser encoding and AI reconstruction. Researchers have introduced a new imaging method that reveals far more ...

Drug Farm today announced that preliminary immunologic and clinical results from its Phase 1b study of DF-003, a first-in-class oral ALPK1 inhibitor, will be presented in a podium session at ...

Most recently, Dr Moses served as Chair of Dark Blue Therapeutics, an Oxford-based oncology biotech which was acquired by ...

The East Asian Subtropical Westerly Jet (EASWJ) and the East Asian Summer Monsoon (EASM) are two pivotal components of the ...

The results show that, on the interannual time scale, the northwest–southeast displacement of the EASWJ and the intensity of ...

As a synthetic decapeptide structurally derived from gonadotropin-releasing hormone (GnRH), Triptorelin has long attracted research interest due to its unusually paradoxical signalling profile.